These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31542988)

  • 1. Age-Related Differences in Medication Adherence, Symptoms, and Stigma in Poorly Adherent Adults With Bipolar Disorder.
    Smilowitz S; Aftab A; Aebi M; Levin J; Tatsuoka C; Sajatovic M
    J Geriatr Psychiatry Neurol; 2020 Sep; 33(5):250-255. PubMed ID: 31542988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.
    Levin JB; Tatsuoka C; Cassidy KA; Aebi ME; Sajatovic M
    Compr Psychiatry; 2015 Apr; 58():29-36. PubMed ID: 25617964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder.
    Sajatovic M; Levin JB; Sams J; Cassidy KA; Akagi K; Aebi ME; Ramirez LF; Safren SA; Tatsuoka C
    Bipolar Disord; 2015 Sep; 17(6):653-61. PubMed ID: 26529124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Fuentes-Casiano E; Bialko CS; Cassidy KA
    Bipolar Disord; 2012 May; 14(3):291-300. PubMed ID: 22548902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges.
    Sajatovic M; Briggs F; Adeniyi C; Koopman J; Black J; Weise C; Fiorelli N; Yala J; Lesanpezeshki M; Einstadter D; Levin JB
    Psychopharmacol Bull; 2024 Jul; 54(3):60-72. PubMed ID: 38993661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed-methods analysis of internalized stigma correlates in poorly adherent individuals with bipolar disorder.
    Howland M; Levin J; Blixen C; Tatsuoka C; Sajatovic M
    Compr Psychiatry; 2016 Oct; 70():174-80. PubMed ID: 27557395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder.
    Sajatovic M; Levin JB; Ramirez LF; Cassidy KA; McNamara N; Fuentes-Casiano E; Wilson B; Appling D; S FB
    Prim Care Companion CNS Disord; 2021 Sep; 23(5):. PubMed ID: 34534421
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder.
    Sajatovic M; Micula-Gondek W; Tatsuoka C; Bialko C
    Gend Med; 2011 Aug; 8(4):261-8. PubMed ID: 21763217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence.
    Sajatovic M; Levin JB; Modi A; McVoy M; Forthun LF; Cooley R; Black J; Conroy C; Sarna K; Briggs FB; DelBello M
    Psychopharmacol Bull; 2023 Aug; 53(3):8-21. PubMed ID: 37601085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder.
    Levin JB; DelBello M; Modi AC; Briggs F; Forthun LF; McVoy M; Yala J; Cooley R; Black J; Conroy C; Sajatovic M
    Bipolar Disord; 2024 Nov; 26(7):696-707. PubMed ID: 39231780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication.
    Sajatovic M; Levin J; Fuentes-Casiano E; Cassidy KA; Tatsuoka C; Jenkins JH
    Compr Psychiatry; 2011; 52(3):280-7. PubMed ID: 21497222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Williams TD; Bialko CS; Cassidy KA
    Psychiatr Serv; 2012 Feb; 63(2):176-8. PubMed ID: 22302337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.
    Fung VC; Overhage LN; Sylvia LG; Reilly-Harrington NA; Kamali M; Gao K; Shelton RC; Ketter TA; Bobo WV; Thase ME; Calabrese JR; Tohen M; Deckersbach T; Nierenberg AA
    J Affect Disord; 2019 Oct; 257():17-22. PubMed ID: 31299400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report.
    McVoy M; Delbello M; Levin J; Modi AC; Forthun LF; Briggs F; Appling D; Broadnax M; Conroy C; Cooley R; Eapen G; Sajatovic M
    Contemp Clin Trials; 2022 Apr; 115():106729. PubMed ID: 35278693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.
    Badiee J; Riggs PK; Rooney AS; Vaida F; Grant I; Atkinson JH; Moore DJ;
    AIDS Patient Care STDS; 2012 Jul; 26(7):388-94. PubMed ID: 22686169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.
    Moore DJ; Posada C; Parikh M; Arce M; Vaida F; Riggs PK; Gouaux B; Ellis RJ; Letendre SL; Grant I; Atkinson JH;
    AIDS Behav; 2012 Nov; 16(8):2257-66. PubMed ID: 22041931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of temperament on the treatment adherence of bipolar disorder type I.
    Buturak SV; Emel EB; Koçak OM
    Nord J Psychiatry; 2016; 70(3):176-82. PubMed ID: 26207348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial.
    Levin JB; Moore DJ; Depp C; Montoya JL; Briggs F; Rahman M; Stange KC; Einstadter D; Weise C; Conroy C; Yala J; Radatz E; Sajatovic M
    Trials; 2022 Jun; 23(1):539. PubMed ID: 35768875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.